Stuart Rich
2022
In 2022, Stuart Rich earned a total compensation of $468.1K as Chief Medical Officer at Tenax Therapeutics, a 43% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $92,700 |
|---|---|
| Option Awards | $52,148 |
| Salary | $309,000 |
| Other | $14,296 |
| Total | $468,144 |
Rich received $309K in salary, accounting for 66% of the total pay in 2022.
Rich also received $92.7K in non-equity incentive plan, $52.1K in option awards and $14.3K in other compensation.
Rankings
In 2022, Stuart Rich's compensation ranked 4,459th out of 5,760 executives tracked by ExecPay. In other words, Rich earned more than 22.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,459 out of 5,760 | 23rd |
Division Manufacturing | 2,510 out of 3,136 | 20th |
Major group Chemicals And Allied Products | 1,206 out of 1,422 | 15th |
Industry group Drugs | 1,133 out of 1,323 | 14th |
Industry Pharmaceutical Preparations | 827 out of 969 | 15th |
Source: SEC filing on April 28, 2023.
Rich's colleagues
We found two more compensation records of executives who worked with Stuart Rich at Tenax Therapeutics in 2022.